bioAffinity Technologies BIAF Edges Higher Amidst Support Test Potential for Breakout US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate OXLCG Q4 2025 Earnings EPS Misses Estimates Modest Stock Uptick US Signals Stable Equilibrium Strategy to Counter China Influence Hegseth Says